Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In this issue, de Jong et al.(https://doi.org/10.1084/jem.20170308) identify bi-allelic loss-of-expression, loss-of-function mutations of the calcium- and integrin-binding protein 1 (<i>CIB1</i>) gene as a new cause of epidermodysplasia verruciformis (EV) and demonstrate that the CIB1 interacts with the EVER1 and EVER2 proteins to form a complex involved in keratinocyte-intrinsic immune response to human β-papillomaviruses (β-HPVs).
|
30068545 |
2018 |
Epidermodysplasia Verruciformis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Collectively, these findings suggest that the disruption of CIB1-EVER1-EVER2-dependent keratinocyte-intrinsic immunity underlies the selective susceptibility to β-HPVs of EV patients.
|
30068544 |
2018 |
Epidermodysplasia Verruciformis
|
0.600 |
Biomarker
|
disease |
BEFREE |
A breakthrough in our understanding of EV was the discovery that homozygous inactivating mutations in TMC6 (EVER1) and TMC8 (EVER2) determine susceptibility to this disorder; however, they have not solved all EV cases fully.
|
28196644 |
2017 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Novel TMC8 splice site mutation in epidermodysplasia verruciformis and review of HPV infections in patients with the disease.
|
28646613 |
2017 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Inactivating mutations in EVER1/EVER2 account for most cases of EV.
|
27087313 |
2016 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Epidermodysplasia Verruciformis is a rare condition of extreme susceptibility to cutaneous HPV infection primarily attributable to mutations in TMC6 and TMC8.
|
25853559 |
2015 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Polymerase chain reaction amplification and sequencing of ECM1, EVER1, and EVER2 demonstrated a homozygous point mutation, c.389C>T (p.Thr130Met), in exon 6 of ECM1 and a heterozygous point mutation, c.917 A>T (p.Asn306Ile), in exon 8 in EVER2, known to cause EV in homozygous patients.
|
23534907 |
2015 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Two genes (TMC6/EVER1 and TMC8/EVER2), mutated in epidermodysplasia verruciformis (EV) patients with an increased risk of cSCC development, contain numerous single-nucleotide polymorphisms (SNPs).
|
26227733 |
2015 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
To determine whether the rs7208422 polymorphism of the EVER2 gene is associated with AK in non-EV patients.
|
25495765 |
2015 |
Epidermodysplasia Verruciformis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus.
|
25378492 |
2015 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Autosomal recessive EVER1 and EVER2 deficiencies account for EV in most patients.
|
22903682 |
2013 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Inactivating mutations in epidermodysplasia verruciformis 1 (EVER1) or EVER2 have been identified in most, but not all, patients with autosomal recessive EV.
|
22850876 |
2012 |
Epidermodysplasia Verruciformis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Our study is a targeted candidate gene follow-up based on: (i) strong clinical evidence demonstrating that mutations in the TMC6 and TMC8 (EVER1 and EVER2) genes associate with the HPV-associated disease epidermodysplasia verruciformis (EV) and (ii) recent epidemiological data suggesting a genetic susceptibility conferred by polymorphisms in such genes for skin and CxCa.
|
21387292 |
2012 |
Epidermodysplasia Verruciformis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Autosomal recessive (AR) EVER1 and EVER2 deficiencies account for two thirds of known cases of EV.
|
22952854 |
2012 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Homozygosity for the c.917A→T (p.N306l) polymorphism in the EVER2/TMC8 gene of two sisters with epidermodysplasia verruciformis Lewandowsky-Lutz originally described by Wilhelm Lutz.
|
21196704 |
2011 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We present epidermodysplasia verruciformis in a father and a son with typical histologic and clinical findings that occur in the absence of mutations in EVER1 or EVER2.
|
19706093 |
2009 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
|
19005244 |
2009 |
Epidermodysplasia Verruciformis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Inactivating mutations in either of the related EVER1/TMC6 and EVER2/TMC8 genes cause most EV cases.
|
18727487 |
2008 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
LHGDN |
Novel homozygous nonsense TMC8 mutation detected in patients with epidermodysplasia verruciformis from a Brazilian family.
|
17711520 |
2007 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We describe a patient with EV and a novel homozygous gene mutation of EVER2 gene who was treated successfully with topical imiquimod.
|
17368633 |
2007 |
Epidermodysplasia Verruciformis
|
0.600 |
Biomarker
|
disease |
BEFREE |
The growing number of mutations in EV pedigrees supports the hypothesis that EVER1 and EVER2 are the molecular basis of EV.
|
17008061 |
2006 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In this study, we performed mutation detection for the EVER1 and EVER2 genes on samples from a Chinese patient with EV, who had consanguineous parents.
|
16045695 |
2005 |
Epidermodysplasia Verruciformis
|
0.600 |
Biomarker
|
disease |
BEFREE |
TMC6 and TMC8 are identical to the EVER1 and EVER2 genes implicated in epidermodysplasia verruciformis, a recessive disorder comprising susceptibility to cutaneous human papilloma virus infections and associated nonmelanoma skin cancers, providing additional genetic and tissue systems in which to study the TMC gene family.
|
12906855 |
2003 |
Epidermodysplasia Verruciformis
|
0.600 |
GeneticVariation
|
disease |
LHGDN |
Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.
|
12426567 |
2002 |
Epidermodysplasia Verruciformis
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.
|
12426567 |
2002 |